PWA
ZYNE

PCG Wealth Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

PCG Wealth Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,200
Closed -$12K – 154
2022
Q3 		$12K Buy
+15,200
New +$12K ﹤0.01% 136
2022
Q1 		– Sell
-11,900
Closed -$34K – 94
2021
Q4 		$34K Buy
+11,900
New +$34K 0.02% 79